Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00251030 · ClinicalTrials.gov registry record · Phase 4
A Study To Estimate The Effect Of Omeprazole On The Pharmacokinetics Of Nelfinavir In Healthy Subjects
A Phase 4 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00251030: Completed Phase 4 study, sponsored by Pfizer.
NCT00251030 is a Phase 4 study that has completed, run by Pfizer. The registered enrollment target is 20 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00251030, a Phase 4 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
To estimate the effects of omeprazole on the pharmacokinetics of nelfinavir in healthy subjects
Interventions
- DRUG Nelfinavir and Omeprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-11 |
| Est. Completion | 2006-01 |
| Phase | Phase 4 |
What the finished NCT00251030 record still lists
NCT00251030 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Nelfinavir and Omeprazole is the first listed.
NCT00251030 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00251030 about?
NCT00251030 is a clinical study titled "A Study To Estimate The Effect Of Omeprazole On The Pharmacokinetics Of Nelfinavir In Healthy Subjects". To estimate the effects of omeprazole on the pharmacokinetics of nelfinavir in healthy subjects
What is the current status of trial NCT00251030?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2005-11. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00251030?
The interventions under investigation include: Nelfinavir and Omeprazole (DRUG).
Who is sponsoring clinical trial NCT00251030?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00251030's enrollment target sits among peer trials
20 1753rd of 2000 higher than 167 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia